Manufacturers have mainly stayed on the periphery of the discussion about how to remedy the issue of unused or wasted drugs from single-use vials, but the REFUND Act is changing that.
Loosening of COVID-19 restrictions in healthcare facilities requires stringent cleanliness policies to curb the spread of infection.
A number of payment rule changes and unknown future federal and state regulations loom ahead.
Value-based healthcare prioritizes positive outcomes and positions patients at the center of future healthcare systems.
The pandemic has left the healthcare system with staffing and revenue shortages, as well as supply chain management challenges, that are expected to extend into the foreseeable future.
Now, more than ever, healthcare provider organizations can benefit from leveraging the broad value of accreditation.
Understanding the factors contributing to the current shortage of immune globulin could help to address a crisis that threatens dire consequences for patients.
Understanding terms used in rule sets pertaining to payment for inpatients, which go into effect during the fiscal year effective Oct. 1, as well as outpatient and physician fee services, which go into effect during the calendar year effective Jan. 1.
Retail health centers are increasingly offering convenient care at lower prices, but debate surrounds their entry into the primary care arena.
The proposed 2022 outpatient prospective payment system (OPPS)/ambulatory surgery center (ASC) and physician fee schedule (PFS) rule sets impact all pharmacy practices.
Expansion of sites of care may soon provide more options for patients and caregivers.
In today’s fast-paced healthcare industry, naiveté about payers’ requirements coupled with their supply chain stipulations can lead to reimbursement shock!
